Lys and Kenalog drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lys (lysine) and Kenalog (triamcinolone acetonide). Common drug interactions include vaginal discharge among females and hypersensitivity among males.

The phase IV clinical study analyzes what interactions people have when they take Lys and Kenalog. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Lys?

Lys has active ingredients of lysine. eHealthMe is studying from 16,532 Lys users. Check the latest studies of Lys.

What is Kenalog?

Kenalog has active ingredients of triamcinolone acetonide. It is often used in pain. eHealthMe is studying from 10,692 Kenalog users. Check the latest studies of Kenalog.

On Aug, 02, 2026

29 people who take Lys and Kenalog together, and have interactions are studied.

What are the common drug interactions of Lys and Kenalog, by gender? *:

female:

Vaginal discharge
Vaginal ulceration
Viral infection
Fatigue (feeling of tiredness)
Accident at home
Foot fracture
Oropharyngeal pain
Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Osteochondrosis (a family of orthopaedic diseases of the joint that occur in children and adolescents)

male:

Hypersensitivity
Blood magnesium decreased
Hypoacusis (loss of hearing)
Insomnia (sleeplessness)
Nervous system disorder (a general class of medical conditions affecting the nervous system)
Pain in extremity
Agitation (state of anxiety or nervous excitement)
Angiofibroma (small, reddish brown or even flesh-coloured, smooth, shiny, 0.1- to 0.3 cm papules present over the sides of the nose and the medial portions of the cheeks)
Blood pressure increased
Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)

What are the common drug interactions of Lys and Kenalog, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Neoplasm (tumour)

20-29:

Respiratory tract congestion (blockage on respiratory system)
Vaginal ulceration
Blood magnesium decreased
Blood potassium decreased
Ear infection
Hypersensitivity
Irritability
Oral pain
Upper respiratory tract infection
Fungal infection

30-39:

n/a

40-49:

Lung disorder (lung disease)

50-59:

n/a

60+:

Fatigue (feeling of tiredness)
Accident at home
Diarrhoea
Hallucination (an experience involving the perception of something not present)
Immunoglobulins decreased
Psychotic disorder
Constipation
Nausea (feeling of having an urge to vomit)
Weight decreased
Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)

What are the existing conditions these people have? *

Primary Immunodeficiency Syndrome: 5 people, 17.24%
Immunodeficiency Common Variable: 5 people, 17.24%
Angiomyolipoma (most common benign tumour of the kidney): 4 people, 13.79%
High Blood Cholesterol: 4 people, 13.79%
Insomnia (sleeplessness): 3 people, 10.34%
Nausea (feeling of having an urge to vomit): 3 people, 10.34%
Wheezing (a high-pitched whistling sound made while you breath): 3 people, 10.34%
Stress And Anxiety: 3 people, 10.34%
Neuralgia (pain in one or more nerves): 2 people, 6.90%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Lys and Kenalog?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously